HOME > TOP STORIES

TOP STORIES

BUSINESS Daiichi Sankyo Espha to Launch Micardis AG, Will Actively Handle Competitors’ Products

January 27, 2017
REGULATORY MHLW Warns Against Purchasing Harvoni in Unpackaged Bottles

January 26, 2017
REGULATORY (Update) Chuikyo Agrees to Shed US Price from Foreign Price Adjustment Rule

January 25, 2017
REGULATORY Counterfeit Harvoni Found in Tokyo Too, Route Identified for a Nara Bottle

January 24, 2017
BUSINESS Ferring Speeding Up R&D in Core Sectors, Positive on Licensing and M&A: Japan CEO

January 23, 2017
ORGANIZATION JGA Head Frets Majority of Products Subject to Gap-Year Revisions Will Be Generics

January 20, 2017
BUSINESS Gilead Japan to Switch Sovaldi, Harvoni Bottles to Blister Packs

January 19, 2017
ORGANIZATION JMA’s Nakagawa Pushes Price Cuts Even on Non-100 Billion Yen Products, Eyes Other Hep C Drugs

January 18, 2017
REGULATORY Counterfeit Harvoni Discovered in Nara Pharmacy, MHLW Investigating Route of Entry into Distribution

January 18, 2017
REGULATORY MHLW to Ponder Additional Gap-Year Price Survey Method That Won’t Cripple Single-Product, Single-Price Efforts: Kanda

January 17, 2017
INTERVIEW MHLW’s Sakoi Calls on Industry to Transcend Corporate Boundaries, Join Pricing Reform Debate

January 16, 2017
REGULATORY PMDA Stops Increasing Review Staff, Current Review-Time Targets to Remain Unchanged: Chief Executive

January 16, 2017
REGULATORY Industry Speculating Tax Hike Will Delay Annual Revision Rollout to 2021

January 13, 2017
REGULATORY Chuikyo Industry, Doctor Reps in Discord over Scope of Price Review for Indication Expansions

January 12, 2017
BUSINESS Ariad Deal Is “Global Acquisition” Not Limited to US Market: Takeda CEO

January 11, 2017
REGULATORY Chuikyo to Kick Off Debates to Elaborate Pricing Revamp; 2 Industry Hearing Sessions Planned

January 11, 2017
BUSINESS Opdivo Gastric Cancer Filing Casts Cloud on Keytruda’s Sakigake Status

January 10, 2017
BUSINESS Takeda to Buy US Oncology Firm Ariad

January 10, 2017
REGULATORY MHLW to Regularly Compile Optimal Drug Use Guidelines from FY2017: Pharma Bureau Chief

January 6, 2017
REGULATORY From Regulatory Agency to Industry-Fostering Agency: Health Minister

January 5, 2017

ページ

COMMENTARY

Evolving GLP-1 Drugs: Could Double and Triple Agonists Achieve Blockbuster Status?

By Shinya Sato

The global race to develop so-called “double G” and “triple G” agonists is heating up to boost the efficacy of…

COLUMN

4 Things Your Firm Can Do to Attract and Retain Top Talent in Japan’s Pharmaceutical and Medical Device Industry

By Philip Carrigan

1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…